We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$1.1B
Cap. Flow
+$840M
Cap. Flow %
6.56%
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$16.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$15.2M
3
T icon
AT&T
T
+$14.3M
4
XOM icon
ExxonMobil
XOM
+$14.1M
5
IBM icon
IBM
IBM
+$13.3M

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Healthcare 14.47%
3 Technology 14.27%
4 Communication Services 9.94%
5 Consumer Staples 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIEN icon
1576
Ciena
CIEN
$47.4B
$357K ﹤0.01%
19,063
-404
-2% -$7.32K
THRM icon
1577
Gentherm
THRM
$1.17B
$357K ﹤0.01%
10,434
-1,718
-14% -$65.3K
FMBI
1578
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$357K ﹤0.01%
20,325
-3,273
-14% -$58.9K
NSP icon
1579
Insperity
NSP
$1.97B
$356K ﹤0.01%
9,214
-758
-8% -$24.5K
HMSY
1580
DELISTED
HMS Holdings Corp.
HMSY
$356K ﹤0.01%
20,220
-876
-4% -$14.1K
MELI icon
1581
Mercado Libre
MELI
$92.7B
$355K ﹤0.01%
2,521
-1,274
-34% -$165K
ASTE icon
1582
Astec Industries
ASTE
$941M
$354K ﹤0.01%
6,306
-144
-2% -$7.31K
BCO icon
1583
Brink's
BCO
$4.48B
$354K ﹤0.01%
12,408
MYGN icon
1584
Myriad Genetics
MYGN
$371M
$354K ﹤0.01%
11,577
-1,481
-11% -$51.5K
PZZA icon
1585
Papa John's
PZZA
$682M
$353K ﹤0.01%
5,184
-840
-14% -$51.2K
FBR
1586
DELISTED
Fibria Celulose Sa
FBR
$353K ﹤0.01%
52,248
-4,551
-8% -$38.7K
VAC icon
1587
Marriott Vacations Worldwide
VAC
$3.48B
$352K ﹤0.01%
5,133
-1,161
-18% -$72.7K
WSBF icon
1588
Waterstone Financial
WSBF
$382M
$352K ﹤0.01%
22,975
-1,224
-5% -$17.5K
ANF icon
1589
Abercrombie & Fitch
ANF
$5.74B
$351K ﹤0.01%
19,686
-4,420
-18% -$105K
BKE icon
1590
Buckle
BKE
$2.04B
$351K ﹤0.01%
13,521
-1,329
-9% -$35.8K
IPXL
1591
DELISTED
Impax Laboratories, Inc.
IPXL
$351K ﹤0.01%
12,168
-1,903
-14% -$62K
GK
1592
DELISTED
G&K Services Inc
GK
$351K ﹤0.01%
4,578
-7
-0.2% -$516
FFBC icon
1593
First Financial Bancorp
FFBC
$3.43B
$349K ﹤0.01%
17,964
-753
-4% -$14.4K
ECOL
1594
DELISTED
US Ecology, Inc.
ECOL
$349K ﹤0.01%
7,595
+585
+8% +$25.9K
SCTY
1595
DELISTED
SolarCity Corporation
SCTY
$349K ﹤0.01%
14,579
+4,927
+51% +$121K
MATW icon
1596
Matthews International
MATW
$627M
$348K ﹤0.01%
6,258
-28
-0.4% -$1.48K
SBGI icon
1597
Sinclair Inc
SBGI
$1.02B
$346K ﹤0.01%
11,597
-15,849
-58% -$496K
WAL icon
1598
Western Alliance Bancorporation
WAL
$8.62B
$346K ﹤0.01%
10,589
-2
-0% -$70
IPAR icon
1599
Interparfums
IPAR
$3.52B
$345K ﹤0.01%
12,087
-54
-0.4% -$1.62K
TSL
1600
DELISTED
Trina Solar Limited
TSL
$343K ﹤0.01%
44,265
-2,189
-5% -$18.8K

Similar funds

Aperio Group's Q2 2016 Portfolio in Review

As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.

  • Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
  • Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
  • Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
  • Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
  • Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
  • Aperio Group opened 79 new positions and closed 98 in Q2 2016.
  • Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.

Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.